News | Interventional Radiology | December 12, 2018

Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018

Company highlights injection management tools, new product launches and joint RSNA scholarship grant awardee

Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018

December 12, 2018 — Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors, disposables, digital solutions and services at the 2018 annual meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.

At Guerbet's booth, interactive workstations provided live demonstrations of novel clinical tools for diagnostic and interventional imaging, including:

  • Contrast & Care, a next-level contrast media injection management solution that enables imaging centers to collect, archive, examine and share data directly with Guerbet's injectors to help radiologists with patient care; and
  • Imalogix, a new self-learning neural network that enables organizations to understand and benchmark best practices from the mass learnings in real time across a network of providers to drive continuous improvement.

Guerbet also highlighted additional key milestones achieved this year, including:

  • Product launches:
  • Partnership:
    • Joined forces with the Association for Medical Imaging Management (AHRA) "Defining Our Future" campaign, an initiative to support the education, development, and empowerment of new and future medical imaging professionals.

Guerbet's macrocyclic ionic contrast agent Dotarem (gadoterate meglumine) remains the first and only macrocyclic and ionic GBCA molecule approved by the U.S. Food and Drug Administration (FDA), according to the company, recently surpassing its 85 millionth dose worldwide. This year, Guerbet is celebrating the five-year anniversary of Dotarem's U.S. launch in March 2013 (and its first pediatric and adult injections in July and September 2013 respectively), all on the heels of Dotarem's "under age 2" pediatric approval last September.

Guerbet also celebrated the granting of the Guerbet/RSNA Research Scholar Grant, by the RSNA Research & Education Foundation to Avener Meoded, M.D., of Johns Hopkins University.  The $150,000 two-year grant will help fund Meoded's research using a comprehensive "omics" approach in the study of brain neuroplasticity in pediatric arterial ischemic stroke.

For more information: www.guerbet.com

Related Content

New ESC Guideline Provides Class 1 Recommendation for Coronary CTA
News | CT Angiography (CTA) | September 17, 2019
The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary...
The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology

The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology. Image courtesy of Siemens Healthineers.

Technology | Angiography | September 17, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
3D Systems Earns Additional FDA Clearance for D2P Medical 3-D Printing Software

3D Systems’ D2P FDA-cleared software allows clinicians to 3-D-print diagnostic patient-specific anatomic models. Image courtesy of 3D Systems.

Technology | Medical 3-D Printing | September 12, 2019
3D Systems has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its D2P software...
FDA Clears GE Healthcare's Critical Care Suite Chest X-ray AI
Technology | X-Ray | September 12, 2019
GE Healthcare announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of Critical Care Suite, a...
Richardson Healthcare Receives CE Mark Approval for ALTA750 Canon/Toshiba CT Replacement Tube
News | Computed Tomography (CT) | September 11, 2019
Richardson Healthcare, a Division of Richardson Electronics Ltd., announced it has received CE Mark approval for the...
Bayer Introduces Medrad Stellant Flex CT Injection System
Technology | Contrast Media Injectors | September 11, 2019
Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection system. Stellant Flex...
iCAD's ProFound AI Wins Best New Radiology Solution in 2019 MedTech Breakthrough Awards
News | Computer-Aided Detection Software | September 09, 2019
iCAD Inc. announced MedTech Breakthrough, an independent organization that recognizes the top companies and solutions...
Imaging Biometrics and Medical College of Wisconsin Awarded NIH Grant
News | Neuro Imaging | September 09, 2019
Imaging Biometrics LLC (IB), in collaboration with the Medical College of Wisconsin (MCW), has received a $2.75 million...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used deep learning, a form of machine learning, which is a type of artificial intelligence. Image courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Society of Breast Imaging (SBI) | September 06, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.